Targeting of Porous Hybrid Silica Nanoparticles to Cancer Cells

被引:445
作者
Rosenholm, Jessica M. [2 ]
Meinander, Annika [1 ,3 ,4 ]
Peuhu, Emilia [1 ,3 ,4 ]
Niemi, Rasmus [1 ]
Eriksson, John E. [1 ,3 ,4 ]
Sahlgren, Cecilia [1 ,3 ,4 ]
Linden, Mika [2 ]
机构
[1] Abo Akad Univ, Dept Biol, FI-20520 Turku, Finland
[2] Abo Akad Univ, Dept Phys Chem, Ctr Funct Mat, FI-2500 Turku, Finland
[3] Univ Turku, Turku Ctr Biotechnol, FI-20521 Turku, Finland
[4] Abo Akad Univ, FI-20521 Turku, Finland
关键词
Cellular targeting; mesoporous silica; bioimaging; nanoparticles; surface functionalization; MESOPOROUS SILICA; DRUG-DELIVERY; INTRACELLULAR DELIVERY; CONTROLLED-RELEASE; SURFACE; SYSTEMS; FUNCTIONALIZATION; NANODEVICE; PARTICLES; POLYMERS;
D O I
10.1021/nn800781r
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Mesoporous silica nanoparticles functionalized by surface hyperbranching polymerization of poly(ethylene imine), PEI, were further modified by introducing both fluorescent and targeting moieties, with the aim of specifically targeting cancer cells. Owing to the high abundance of folate receptors in many cancer,cells as compared to normal cells, folic acid was used as the targeting ligand. The internalization of the particles in cell lines expressing different levels of folate receptors was studied. Flow cytometry was used to quantify the mean number of nanoparticles internalized per cell. Five times more particles were internalized by cancer cells expressing folate receptors as compared to the normal cells expressing low levels of the receptor. Not only the number of nanoparticles internalized per cell, but also the fraction of cells that had internalized nanoparticles was higher. The total number of particles internalized by the cancer cells was, therefore, about an order of magnitude higher than the total number of particles internalized by normal cells, a difference high enough to be of significant biological importance. In addition, the biospecifically tagged hybrid PEI-silica particles were shown to be noncytotoxic and able to specifically target folate receptor-expressing cancer cells also under coculture conditions.
引用
收藏
页码:197 / 206
页数:10
相关论文
共 50 条
[1]   Ligand based dendritic systems for tumor targeting [J].
Agarwal, Abhinav ;
Saraf, Surbhi ;
Asthana, Abhay ;
Gupta, Umesh ;
Gajbhiye, Virendra ;
Jain, Narendra K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 350 (1-2) :3-13
[2]   Influences of material characteristics on ibuprofen drug loading and release profiles from ordered micro- and mesoporous silica matrices [J].
Andersson, J ;
Rosenholm, J ;
Areva, S ;
Lindén, M .
CHEMISTRY OF MATERIALS, 2004, 16 (21) :4160-4167
[3]  
[Anonymous], NANOTECHNOLOGY CANC
[4]   Silica particles:: A novel drug-delivery system [J].
Barbé, C ;
Bartlett, J ;
Kong, LG ;
Finnie, K ;
Lin, HQ ;
Larkin, M ;
Calleja, S ;
Bush, A ;
Calleja, G .
ADVANCED MATERIALS, 2004, 16 (21) :1959-1966
[5]  
BERGMAN L, 2006, BIOMACROMOLECULES, V7, P572
[6]   On the complexity of electrostatic suspension stabilization of functionalized silica nanoparticles for biotargeting and imaging applications [J].
Bergman, Lotta ;
Rosenholm, Jessica ;
Ost, Anna-Brita ;
Duchanoy, Alain ;
Kankaanpaa, Pasi ;
Heino, Jyrki ;
Linden, Mika .
JOURNAL OF NANOMATERIALS, 2008, 2008
[7]   Sol-gel carrier systems for controlled drug delivery [J].
Böttcher, H ;
Slowik, P ;
Süss, W .
JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY, 1998, 13 (1-3) :277-281
[8]   Nanoparticle and targeted systems for cancer therapy [J].
Brannon-Peppas, L ;
Blanchette, JO .
ADVANCED DRUG DELIVERY REVIEWS, 2004, 56 (11) :1649-1659
[9]   Folate receptor-α is a cofactor for cellular entry by Marburg and Ebola viruses [J].
Chan, SY ;
Empig, CJ ;
Welte, FJ ;
Speck, RF ;
Schmaljohn, A ;
Kreisberg, JF ;
Goldsmith, MA .
CELL, 2001, 106 (01) :117-126
[10]   The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats [J].
Chandrasekar, Durairaj ;
Sistla, Ramakrishna ;
Ahmad, Farhan J. ;
Khar, Roop K. ;
Diwan, Prakash V. .
BIOMATERIALS, 2007, 28 (03) :504-512